{Reference Type}: Journal Article
{Title}: High systemic inflammatory response index (SIRI) is an independent risk factor for poor outcome in IgA nephropathy patients.
{Author}: Yang D;Zhou H;Qin W;
{Journal}: Int Urol Nephrol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 26
{Factor}: 2.266
{DOI}: 10.1007/s11255-024-04171-w
{Abstract}: <B>BACKGROUND: </B>The systemic inflammatory response index (SIRI), a straightforward and easily accessible measure of inflammation and prognosis, has drawn more attention lately. It is unknown, however, if SIRI is important for IgA nephropathy (IgAN) patients' outcomes. To better clarify these concerns, we conducted this investigation.<BR><B>METHODS: </B>This retrospective study involved 981 patients with biopsy-confirmed IgAN from West China Hospital of Sichuan University between 2008 and 2019. The patients were divided into two groups based on the SIRI's optimal cut-off value calculated by the X-tile: the low SIRI group (SIRI ≤ 0.63, n = 312) and the high SIRI group (SIRI > 0.63, n = 669). Basic clinical characteristics at the time of renal biopsy were evaluated, and the relationship between SIRI and the combined endpoint was analyzed. We also used the Cox proportional hazard model and Kaplan‒Meier curve to evaluate the renal prognosis of IgAN.<BR><B>RESULTS: </B>A total of 981 IgAN patients were included. During a median follow-up period of 56.7 months (36.8-80.4 months), 122 patients progressed to the combined endpoint (12.4%). Patients were divided into a low SIRI group (SIRI ≤ 0.63, n = 312) and a high SIRI group (SIRI > 0.63, n = 669) according to the optimal cut-off value of the systemic inflammatory response index (SIRI). Further analysis showed that a higher SIRI value was significantly associated with the risk of IgAN patients reaching the composite endpoint (HR 1.62, 95% CI 1.02-2.56, p = 0.041).<BR><B>CONCLUSIONS: </B>High SIRI is a significant and independent risk factor for renal disease progression in IgAN patients.